KHTRF
KNIGHT THERAPEUTICS INC by Knight Therapeutics Inc (KHTRF)
$41
About KNIGHT THERAPEUTICS INC by Knight Therapeutics Inc (KHTRF)
Knight Therapeutics, Inc. engages in the business of acquiring, in licensing, out-licensing, marketing, and commercializing pharmaceuticals products. The firm also focuses on building a portfolio of innovative products through in-licensing or acquiring product rights. The company was founded by Jonathan Ross Goodman on November 1, 2013 and is headquartered in Montréal, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$4.72
52 Week Low
$3.48
Market cap
437.5M
Dividend yield
0.00%
Volume
--
Avg. volume
794
P/E ratio
-162.06
KNIGHT THERAPEUTICS INC by Knight Therapeutics Inc News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$4.72
52 Week Low
$3.48
Market cap
437.5M
Dividend yield
0.00%
Volume
--
Avg. volume
794
P/E ratio
-162.06